Geode Capital Management
AERI

Geode Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Geode Capital Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-862,809
Closed -$13.1M – 5032
2022
Q3 		$13.1M Buy
862,809
+27,423
+3% +$319K ﹤0.01% 2052
2022
Q2 		$6.26M Buy
835,386
+71,654
+9% +$505K ﹤0.01% 2576
2022
Q1 		$6.95M Sell
763,732
-74,581
-9% -$575K ﹤0.01% 2597
2021
Q4 		$5.88M Buy
838,313
+184,703
+28% +$1.93M ﹤0.01% 2807
2021
Q3 		$7.45M Sell
653,610
-102,604
-14% -$1.5M ﹤0.01% 2677
2021
Q2 		$12.1M Buy
756,214
+58,927
+8% +$1.01M ﹤0.01% 2324
2021
Q1 		$12.5M Buy
697,287
+67,896
+11% +$1.17M ﹤0.01% 2211
2020
Q4 		$8.5M Buy
629,391
+20,282
+3% +$245K ﹤0.01% 2281
2020
Q3 		$7.17M Sell
609,109
-2,663
-0.4% -$32.4K ﹤0.01% 2173
2020
Q2 		$9.03M Sell
611,772
-25,142
-4% -$372K ﹤0.01% 1971
2020
Q1 		$8.6M Buy
636,914
+44,751
+8% +$849K ﹤0.01% 1832
2019
Q4 		$14.3M Buy
592,163
+38,470
+7% +$797K ﹤0.01% 1763
2019
Q3 		$10.6M Buy
553,693
+20,117
+4% +$461K ﹤0.01% 1893
2019
Q2 		$15.8M Buy
533,576
+59,128
+12% +$2.28M ﹤0.01% 1653
2019
Q1 		$22.5M Buy
474,448
+38,565
+9% +$1.7M 0.01% 1342
2018
Q4 		$15.7M Buy
435,883
+20,539
+5% +$964K ﹤0.01% 1450
2018
Q3 		$25.6M Buy
415,344
+15,175
+4% +$975K 0.01% 1229
2018
Q2 		$27M Buy
400,169
+61,492
+18% +$3.44M 0.01% 1136
2018
Q1 		$18.4M Buy
338,677
+16,587
+5% +$928K 0.01% 1325
2017
Q4 		$19.2M Buy
322,090
+12,859
+4% +$780K 0.01% 1293
2017
Q3 		$15M Buy
309,231
+16,569
+6% +$904K 0.01% 1456
2017
Q2 		$15.4M Buy
292,662
+30,441
+12% +$1.42M 0.01% 1390
2017
Q1 		$11.9M Buy
262,221
+8,365
+3% +$373K ﹤0.01% 1493
2016
Q4 		$9.61M Buy
253,856
+43,322
+21% +$1.64M ﹤0.01% 1605
2016
Q3 		$7.95M Buy
210,534
+24,940
+13% +$550K ﹤0.01% 1648
2016
Q2 		$3.27M Buy
185,594
+24,275
+15% +$393K ﹤0.01% 2166
2016
Q1 		$1.96K Buy
161,319
+925
+0.6% +$14.6K ﹤0.01% 2480
2015
Q4 		$3.9M Buy
160,394
+12,443
+8% +$290K ﹤0.01% 2037
2015
Q3 		$2.62M Buy
147,951
+53,755
+57% +$974K ﹤0.01% 2253
2015
Q2 		$1.66M Buy
94,196
+10,508
+13% +$193K ﹤0.01% 2610
2015
Q1 		$2.62M Buy
83,688
+1,878
+2% +$54.4K ﹤0.01% 2271
2014
Q4 		$2.39M Buy
81,810
+5,738
+8% +$146K ﹤0.01% 2316
2014
Q3 		$1.57M Buy
76,072
+24,831
+48% +$490K ﹤0.01% 2502
2014
Q2 		$1.27M Buy
51,241
+1,772
+4% +$30.7K ﹤0.01% 2649
2014
Q1 		$1.05M Buy
49,469
+12,006
+32% +$243K ﹤0.01% 2769
2013
Q4 		$672K Buy
+37,463
New +$488K ﹤0.01% 2936

Geode Capital Management's AERI Position: Q4 2022 in Review

Geode Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 862,809 shares — an estimated $13.1M sold.

Geode Capital Management first reported a position in AERI in Q4 2013 and held it in 36 quarters. The position peaked at $27M in Q2 2018. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Geode Capital Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Geode Capital Management sold 862,809 Aerie Pharmaceuticals shares in Q4 2022, an estimated $13.1M.
  • Geode Capital Management first reported a position in Aerie Pharmaceuticals in Q4 2013 and held it in 36 quarters.
  • Geode Capital Management's Aerie Pharmaceuticals position peaked at $27M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.